Stock screening is commonly deployed by investors to ‘cut through the noise.’ The approach is especially useful when considering the thousands of options to choose from, which can often overwhelm ...

The collaboration with Plexus is expected to position Evolv for its next phase of growth. Key benefits include increased ...

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the immuno-oncology industry, ...

ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: STAI), a developer of advanced AI-powered security screening and imaging systems, today announced that it has filed restated ...

The 4 immuno-oncology stocks we track reported a stunning Q3. As a group, revenues beat analysts’ consensus estimates by 8.4% ...

With that being said, we’re here with a list of the 12 best upside stocks to buy now.

DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), ...

ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: STAI), a developer of advanced AI-powered security screening and imaging systems, today ...

And finally, Abbott Laboratories' dividend record is an excellent reason to invest in the company. Abbott is a Dividend King, ...

The Company emphasized that the term sheet is non-binding, and any transaction remains subject to the negotiation and execution of definitive agreements, completion of due diligence, and satisfaction ...

Founded in 1991 and evolving from a genomics research firm to a commercial-stage drug developer, Incyte (NASDAQ:INCY) is a biopharmaceutical company that discovers, develops, and commercializes ...

Q3 2025 Earnings Call Transcript November 25, 2025 Operator: Good day, ladies and gentlemen. Thank you for standing by, and ...